Company intelligence
NephCure
25 years closer to a cure for rare kidney disease.
About NephCure
NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible. Since 2000, NephCure has led the revolution in research, new treatments, and care. NephCure is squarely focused on nephrotic syndrome, FSGS, IgAN, and other rare, protein-spilling kidney diseases. NephCure acts as the connector amongst patients and families, healthcare providers, government agencies, industry partners, and other key stakeholders, while also guiding patients to the best care and treatment options possible. NephCure is a U.S. tax exempt 501 (c)(3) public charity established in 2000.
Verified activity
Signals from NephCure
2 published signals
Presence & Recognition
NephCure is hosting its annual Countdown to a Cure Gala on Thursday, November 12, at The Pierre in New York City.
Reported by NephCure
Strategy & Corporate Development
NephCure introduced its new mission statement to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible.
Reported by NephCure